CBD Related News
Exploring the extraction and applications of CBDA
We all know about CBD – but what do we know about CBDA?
When we think about the cannabinoids that can be found in cannabis...
Anspec: applying 27 years of pharmaceutical industry experience to import and export
Australian pharmaceutical supplier, Anspec, is applying its decades of experience to import and export medical cannabis products.
Anspec has more than 27 years of industry experience...
CBD in medicine: relief and regulation
Neuropharmacologist and Functional Medicine practitioner Dr Elisabeth Philipps tells MCN about the therapeutic benefits of CBD and talks about CBD regulation.
MCN speaks to Dr...
The world of sport medicine with Dominic Day
Retired rugby star and co-founder of fourfivecbd Dominic Day highlights the benefits of CBD for an active lifestyle.
Professional rugby player Dominic Day came across...
Tried and tested high quality CBD products, brought to you by Handpicked CBD
Handpicked CBD is the UK’s choice online retail destination for buying tried and tested, high quality CBD products.
The Handpicked CBD team is on a...
Liquid Health Labs and PowerCap® provide solutions for cannabis dosing
Dosing is the cannabis industry’s biggest problem. Amid the boom in legalised cannabis and associated products, dosing is proving to be the biggest challenge...
Medical Cannabis Network Quarterly Issue 2
Medical Cannabis Network Quarterly editor Rosemary Lobley introduces our second edition, which looks at cannabis research, policy and innovation around the world.
Welcome to the...
Khiron launches online cannabis course with Latin American university
A new, online cannabis course has been launched by Khiron Life Sciences in conjunction with Latin American University – Tecnologico de Monterrey.
Cannabis company, Khiron...
The ACI launches new CBD safety certification initiative
The Association for the Cannabinoid Industry (The ACI) today outlined new plans for The ACI CBD Safety Certification programme.
The Association for the Cannabinoid Industry...
CBD at the crossroads: a response to the FSA guidelines
Professor Mike Barnes, co-founder of Maple Tree Consultants, responds to the FSA's guidelines regarding CBD products.
As the cannabis market has grown exponentially over the...
Kalytera Therapeutics: improving bone marrow transplants with CBD
Dr Sari Prutchi Sagiv, CSO at Kalytera Therapeutics Inc., showcases the potential of CBD to revolutionise treatment of Graft versus Host Disease.
The development of...
New study shows that CBD improves efficacy of antibiotics
A new study has shown that the cannabis cannabinoid CBD helps to fight resistant bacteria by improving the efficacy of antibiotics.
Scientists at the University...
Rize ETF: Europe’s most diversified cannabis equity portfolio
Four new companies have been added to Rize ETF’s specialist thematic Exchange Traded Fund (ETF) to create Europe’s most diversified cannabis equity portfolio.
Rize ETF,...
Symtomax: poised for a head start in the European cannabis market
A Portuguese cannabis company, Symtomax, is positioning itself to become the biggest supplier of medical cannabis in the European cannabis market.
Symtomax, a medical cannabis...
Expert answers: can cannabis and CBD affect coronavirus?
In this article, integrative medicine expert, Dr Dani Gordon, answers peoples’ question of whether cannabis and CBD can affect contracting or recovering from COVID-19,...
LeafCann: common misconceptions about cannabis
LeafCann Group CEO Elisabetta Faenza explores harmful myths around medical and adult use cannabis.
Leafcann is aware that perhaps no other plant causes as much...
Medicaleaf: the clarion call for wellness from nature
The Medicaleaf team share their observations and understanding of the driving forces of increasing consumer demand for CBD.
Medicaleaf™ aspires to be a philanthropic and...
Symtomax: what’s the next step for medical cannabis innovation?
Paul Segal, chairman and co-founder of Symtomax, showcases Symtomax’s contribution to innovations in the medical cannabis sector.
2020 is looking to be a remarkable year...
Calls for CBD regulation following inaccurate CBD levels on products
The Digital Citizens Alliance is calling on Congress for CBD regulation as new research has highlighted the inaccuracy of CBD potency levels listed on...
New research examines the impact of CBD on creative flow
A new study is being conducted that looks at the impact of CBD on creative ‘flow’.
The Flow Research Collective and Ojai Energetics have joined...